TARDBP and proteostasis deficiencies: In addition, the presence of secondary TDP-43 pathology in diseases such as AD, chronic traumatic encephalopathy, and PD suggests broader utility in mapping disease heterogeneity and identifying patients at risk of mixed or evolving proteinopathies.